Universe · entity
BML Capital Management, LLC
Institutional manager (13F) · CIK 1616824
13F holdings · as of 2026-03-31 · top 15 · reported portfolio $155M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC | $53M | 14,250,000 |
| 2 | ATEA PHARMACEUTICALS INC | $38M | 7,058,657 |
| 3 | ORAMED PHARMACEUTICALS INC | $11M | 3,167,231 |
| 4 | TILLYS INC | $9M | 2,150,000 |
| 5 | OUTSET MED INC | $7M | 1,902,201 |
| 6 | PMV PHARMACEUTICALS INC | $7M | 5,320,000 |
| 7 | CARMAX INC | $6M | 155,000 |
| 8 | KEZAR LIFE SCIENCES INC | $5M | 720,787 |
| 9 | INSTIL BIO INC | $5M | 645,600 |
| 10 | TARGET CORP | $5M | 37,500 |
| 11 | KRAFT HEINZ CO | $3M | 125,000 |
| 12 | JANUX THERAPEUTICS INC | $2M | 154,961 |
| 13 | PLIANT THERAPEUTICS INC | $2M | 1,546,137 |
| 14 | CONNECT BIOPHARMA HLDGS LTD | $1M | 408,887 |
| 15 | IMAGENEBIO INC | $1M | 200,730 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.